Search EPC Resource Library Only
Search EPC Resource Library & ASN Site
Community Emergency Partners
American Association of Kidney Patients (AAKP) 2 links
American Kidney Fund (AKF) 5 links
Kidney Community Emergency Response (KCER) Coalition 3 links
National Forum of ESRD Networks 5 links
National Kidney Foundation (NKF) 5 links
State Emergency Management Agencies 1 link
Federal Emergency Response Partners
Administration for Strategic Preparedness and Response (ASPR) Technical Resources, Assistance Center and Information Exchange (TRACIE) 3 links
Centers for Medicare & Medicaid Services (CMS) 9 links
- CMS Recognized Current Emergencies
- Medicare Claims During Public Health Emergencies
- CMS Emergency Preparedness FINAL Rule (March 26, 2021-PDF, 75 pages)
- CMS Emergency Preparedness Rule Guidance for Surveyors
- CMS Emergency Preparedness Rule from Healthcare Ready
- CMS After Action Report and Improvement Plan Template and Instructions (access under downloads, ZIP file, Word documents)
- CMS Emergency Preparedness Acronym & Glossary List
- CMS Emergency Preparedness for Dialysis Facilities-A guide for Chronic Dialysis Facilities (PDF, 143 pages)
- CMS Preparing for Emergencies: A Guide for People on Dialysis (PDF, 38 pages)
Centers for Disease Control and Prevention (CDC) 1 link
Federal Emergency Management Agency (FEMA) 3 links
Food and Drug Administration (FDA) 1 link
National Oceanic and Atmospheric Administration 1 link
Diabetic Kidney Disease (DKD-C) Strategy Conference Series
Implementing New Diabetic Kidney Disease Treatments – Time to Act (June 16, 2021) 4 links
Implementing New Diabetic Kidney Disease Treatments – Time to Act (April 20, 2021) 3 links
Monkeypox
Centers for Disease Control and Prevention (CDC) Resources 5 links
Frequently Asked Questions About Monkeypox for the Dialysis Setting 1 link
Diabetic Kidney Disease
General DKD Information 10 links
- Diabetic Kidney Disease: Challenges, Progress, and Possibilities
- The Global Epidemiology of Diabetes and Kidney Disease
- Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database
- KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease
- Preserving Kidney Function Instead of Replacing It
- Implications of Specialist Density for Diabetes Care in the United States
- Cardio-Renal-Metabolic Care Models Toward Achieving Effective Interdisciplinary Care
- Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons Learned
- Health Care Access and Use Among Adults with Diabetes During the COVID-19 Pandemic — United States, February–March 2021
- Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria
Complications of DKD 4 links
- Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
- Global trends in diabetes complications: A review of current evidence
- Changes in Diabetes-Related Complications in the United States, 1990–2010
- Relative Incidence of ESRD Versus Cardiovascular Mortality in Proteinuric Type 2 Diabetes and Nephropathy: Results From the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) Database
Outcomes and Data Associated with DKD 9 links
- Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group: KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease
- Centers for Disease Control and Prevention: National Diabetes Statistics Report
- International Diabetes Federation: IDF Diabetes Atlas, 9th Ed
- Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
- Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
- Heart Disease and Stroke Statistics—2021 Update
- Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children An Analysis of the CURE-CKD Registry
- Vital Signs: Decrease in Incidence of Diabetes-Related End-Stage Renal Disease among American Indians/Alaska Natives — United States, 1996–2013
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of randomised trials.
Medications Associated with DKD 17 links
- Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria
- Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States
- Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
- Dapagliflozin in Patients with Chronic Kidney Disease
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
- Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): A multicentre, open-label, randomised trial
- Prescribing Trends of Antidiabetes Medications in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Cohort Study
- Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease
- Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial
- Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence
- Cost-effectiveness of empagliflozin in patients with diabetic kidney disease in the United States: Findings based on the EMPA-REG OUTCOME Trial
- The Medical Letter: Comparison Chart: Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
- In the Years Before the COVID-19 Pandemic, Nearly 13 Million Adults Delayed or Did Not Get Needed Prescription Drugs Because of Costs
- Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol
DKD and the Pediatric Population 2 links
DKD Payment and Drug Pricing 3 links
DKD and Diversity/Equality 6 links
- Reported Racial Discrimination, Trust in Physicians, and Medication Adherence Among Inner-City African Americans With Hypertension
- Beyond Consent: Building Trusting Relationships with Diverse Populations in Precision Medicine Research
- Effects of Community-Based Health Worker Interventions to Improve Chronic Disease Management and Care Among Vulnerable Populations: A Systematic Review
- A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race
- Time to Eliminate Health Care Disparities in the Estimation of Kidney Function
Diabetic Kidney Disease (DKD-C) Videoconference Series
Management of Diabetes & Kidney Disease through COVID-19 4 links
Goal-Directed Medical Therapies (GDMT) for Patients with Diabetic Kidney Disease and Beyond 3 links
Infectious Diseases
Clostridioides difficile (C-diff or CDI) 2 links
Ebola 7 links
- Ebola Gap Analysis
- Ebola: Responding to a Growing Crisis (webinar)
- ASPR TRACIE: Healthcare System Readiness for Highly Pathogenic Infectious Diseases
- National Emerging Special Pathogens Training and Education
- World Health Organization (WHO): Ebola Virus Disease
- ASPR TRACIE: Highly Pathogenic Infectious Disease Exercise Planning for Front Line Facilities
- U.S. Department of Health & Human Services Topic Collection: VHF/Ebola
Hepatitis A 3 links
Hepatitis B 2 links
Hepatitis C 4 links
- KDIGO Guidelines "Hepatitis C in CKD" (2018)
- KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
- CDC/NTDS Hepatitis C Testing and Monitoring Algorithm
- AJKDBlog: Caring for Patients with Hepatitis C and CKD in the Modern Era: The 2018 KDIGO Guideline
Infection Prevention and Disease Control During Emergencies
Emergency Management in Dialysis 5 links
Asbestos Risks in Disasters 3 links
General Infection Prevention and Control (IPC) Guidance
CDC 8 links
- Core Infection Prevention and Control Practices for Safe Healthcare Delivery in All Settings
- Dialysis Safety: Core Interventions
- Dialysis Safety Index
- Dialysis: Reducing Infections and Changing Culture (podcast)
- Discussion of Respiratory Protection Recommendations for Measles, Varicella, and Disseminated Zoster
- Infection Control in Healthcare Personnel
- Making Dialysis Safer for Patients: Tools to Prevent Infections in Hemodialysis (video)
- Transmission-Based Precautions
CMS 2 links
Environmental Cleaning and Disinfection 3 links
National Healthcare Safety Network (NHSN) 1 link
Publications 6 links
- Essential Components of an Infection Prevention Program for Outpatient Hemodialysis Centers
- 100% Use of Infection Control Procedures in Hemodialysis Facilities: Call to Action
- Evolving Role of the Medical Director of a Dialysis Facility
- Infection control guidelines in hemodialysis facilities
- Leading the Dialysis Unit: Role of the Medical Director
- Maintaining Safety in the Dialysis Facility
Safe Injection Practices 4 links
Bloodstream Infections
Vascular Access Infections 6 links
- Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis
- CDC Approach to BSI Prevention in Dialysis Facilities (i.e., the Core Interventions)
- Catheter-related blood stream infections in hemodialysis patients: a prospective cohort study
- Dialysis BSI Prevention Collaborative
- NHSN Tracking Infections in Outpatient Dialysis Facilities
- CDC Dialysis Safety: Core Interventions
Blood Culture Collection 1 link
NTDS Events
Past Webinars 8 links
- Savings Lives and Saving Money: AI for Improvement in AKI (recorded June 7, 2022)
- ASN COVID-19 Roundtable: Outpatient Therapeutics Webinar (recorded February 11, 2022)
- Management of Clostridioides difficile Infections in Outpatient Hemodialysis Settings (recorded Friday, September 24, 2021)
- Use of Monoclonal Antibodies for the Treatment of Mild to Moderate SARS-COV-2 in Patients Receiving Hemodialysis: A Kidney Community Conversation (recorded March 11, 2021)
- New Approaches to Transform Outcomes for Kidney Disease and Heart Disease in Patients with Diabetes (recorded Thursday, December 10, 2020)
- Goal-Directed Medical Therapies for Patients with Diabetic Kidney Disease (recorded Tuesday, September 29, 2020)
- Management of Diabetes & Kidney Disease through COVID-19 (recorded Tuesday, August 18, 2020)
- COVID-19 Associated AKI Recognition and Management (recorded Tuesday, April 21, 2020)
From ASN eLearning Center 6 links
- NTDS Targeting Zero Infections Webinar Series: Human Factors Engineering and its Application to Dialysis (recorded Tuesday, September 17, 2019)
- Targeting Zero Infections: Hepatitis C Detection, Prevention, and Treatment (recorded Thursday, December 6, 2018)
- Targeting Zero Infections: Environmental Decontamination (recorded Tuesday, June 19, 2018)
- Targeting Zero Infections: Infectious Disease Reporting: State Requirements & Resources (recorded Thursday, March 29, 2018)
- Targeting Zero Infections: MDROs and Antimicrobial Stewardship in the Dialysis Facility (recorded Wednesday, September 27, 2017)
- Targeting Zero Infections: Where Do We Begin? (recorded Tuesday, May 23, 2017)
Shingles Immunization
Recommendations 2 links
Pneumonia Immunization
Recommendations 4 links
Influenza Immunization
Recommendations 2 links
Articles 4 links
- American Journal of Kidney Diseases: “Mortality of Dialysis Patients According to Influenza and Pneumococcal Vaccination Status”
- American Journal of Kidney Diseases: “Influenza and Pneumococcal Vaccination in Dialysis Patients: Merely a Shot in the Arm?
- Clinical Journal of the American Society of Nephrology: “High-Dose Seasonal Influenza Vaccine in Patients Undergoing Dialysis”
- Journal of the American Society of Nephrology: “Racial and Ethnic Disparities in Seasonal Influenza Vaccination among Dialysis Facilities in the United States”
